Galiste, Lesheen .
HRN: 16-66-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
CEFUROXIME 750MG (VIAL)
04/01/2024
04/07/2024
IV
750mg
Q8hrs
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes